Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Oct 2021 07:00 AM
RNS
Notice of Results and Investor Presentation
07 Oct 2021 10:42 AM
RNS
US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor
29 Sep 2021 10:46 AM
RNS
Reference to SRA737 Timeline at Cantor Conference
19 Aug 2021 07:00 AM
RNS
Trading Statement
09 Aug 2021 01:26 PM
RNS
Subscription to raise £1,000,000
06 Aug 2021 07:19 AM
RNS
SRA737 update
30 Jul 2021 07:00 AM
RNS
US Patent Notice of Allowance for SDC-1802
19 Jul 2021 02:05 PM
RNS
Second Price Monitoring Extn
19 Jul 2021 02:01 PM
RNS
Price Monitoring Extension
19 Jul 2021 11:13 AM
RNS
Subscription to raise £1,000,000
14 Jul 2021 07:00 AM
RNS
Exercise of Warrants and Total Voting Rights
01 Jul 2021 07:00 AM
RNS
Covid-19 Research Project Results
24 Jun 2021 02:05 PM
RNS
Second Price Monitoring Extn
24 Jun 2021 02:00 PM
RNS
Price Monitoring Extension
21 Jun 2021 08:00 AM
RNS
Sareum to Present at BioTrinity 2021 Conference
17 Jun 2021 04:40 PM
RNS
Second Price Monitoring Extn
17 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
17 Jun 2021 11:05 AM
RNS
Second Price Monitoring Extn
17 Jun 2021 11:00 AM
RNS
Price Monitoring Extension
16 Jun 2021 02:05 PM
RNS
Second Price Monitoring Extn
16 Jun 2021 02:00 PM
RNS
Price Monitoring Extension
16 Jun 2021 09:06 AM
RNS
Second Price Monitoring Extn
16 Jun 2021 09:00 AM
RNS
Price Monitoring Extension
15 Jun 2021 11:19 AM
RNS
Subscription to raise £1,470,000
14 Jun 2021 04:40 PM
RNS
Second Price Monitoring Extn
14 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
09 Jun 2021 09:05 AM
RNS
Second Price Monitoring Extn
09 Jun 2021 09:00 AM
RNS
Price Monitoring Extension
01 Jun 2021 02:05 PM
RNS
Second Price Monitoring Extn
01 Jun 2021 02:00 PM
RNS
Price Monitoring Extension
01 Jun 2021 11:06 AM
RNS
Second Price Monitoring Extn
01 Jun 2021 11:00 AM
RNS
Price Monitoring Extension
01 Jun 2021 07:00 AM
RNS
Subscription to raise £900,000
25 May 2021 09:05 AM
RNS
Second Price Monitoring Extn
25 May 2021 09:00 AM
RNS
Price Monitoring Extension
25 May 2021 07:00 AM
RNS
Trading Statement
17 May 2021 04:36 PM
RNS
Price Monitoring Extension
13 May 2021 07:00 AM
RNS
Exercise of Options and Total Voting Rights
05 May 2021 01:15 PM
EQS
Sareum Holdings (SAR): Treading the TYK2 trail
05 May 2021 07:00 AM
EQS
Sareum Holdings (SAR): Treading the TYK2 trail
23 Apr 2021 07:00 AM
RNS
Half-year Report
25 Mar 2021 02:07 PM
RNS
Research Update
25 Mar 2021 07:00 AM
RNS
Interim Results Extension
16 Feb 2021 07:00 AM
RNS
Sareum Notes New UK Government Covid-19 Initiative
01 Feb 2021 07:00 AM
RNS
Sareum to Present at the LSX World Congress 2021
26 Jan 2021 07:00 AM
RNS
Sareum to Participate in the Edison Open House
11 Jan 2021 11:06 AM
RNS
Second Price Monitoring Extn
11 Jan 2021 11:01 AM
RNS
Price Monitoring Extension
08 Jan 2021 03:54 PM
RNS
Update re: FLT3+Aurora Kinase Inhibitor Programme
07 Jan 2021 07:00 AM
RNS
US Patent Grant for TYK2/JAK1 Anticancer Candidate

Sareum Holdings Plc (Sareum) is a clinical-stage drug discovery and development company that produces targeted small-molecule therapeutics for treating cancer and autoimmune diseases.

The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor Library (SKIL). The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. Its research programs include Chk1 (checkpoint kinase 1), Aurora+FLT3 kinase, Autoimmune-TYK2/JAK1 kinases, and Cancer-TYK2/JAK1 kinases. Sareum's Chk1 kinase cancer research program is being conducted through joint research collaboration with Cancer Research Technology Limited and the Institute of Cancer Research. Sareum is headquartered in Cambridge, the UK.

SAR share price listed on AIM in 2004 under the ticker SAR.

UK 100

Latest directors dealings